SEARCH Articles Figures Tables Committee for Orphan Medicinal Committee for Orphan Medicinal Products Committee for Orphan Medicinal Products COMP) Cystic fibrosis, orphan drugs Economics orphan drugs Europe orphan drugs Exclusivity orphan drugs Female orphans Gene, genes orphan members Income Support for Orphans and Vulnerable Children Japan orphan drugs Marketing orphan drugs Medicinal chemistry orphan” receptors Medicines orphan Molecular cloning orphan receptors Nurrl nuclear orphan receptor Office of Orphan Products Development Office of Orphan Products Development OOPD) Orphan Drug Act Orphan Drug Amendment Orphan Drug Law Orphan Drug legislation Orphan GPCR receptors Orphan GPCRs Orphan Medical Orphan Medical Inc Orphan Nurrl Orphan Products Board Orphan chemicals Orphan chemokine receptor Orphan criteria Orphan diseases Orphan diseases defined Orphan drug Orphan drug designation Orphan drug status Orphan drugs approved Orphan drugs benefits from development Orphan drugs classification Orphan drugs clinical research grants Orphan drugs current status Orphan drugs definition Orphan drugs development Orphan drugs discovery Orphan drugs distribution Orphan drugs market exclusivity Orphan drugs perspective Orphan drugs principles Orphan drugs protocol assistance Orphan drugs regulatory processes Orphan nuclear receptors Orphan nuclear receptors as xenobiotic receptor Orphan number Orphan opioid receptor Orphan receptors Orphan receptors characterization Orphan receptors drug discovery using Orphan receptors function Orphan target Orphan-Drug Annual Reports Orphan-Drug Applications Orphan-drug designation application Orphaned materials Orphans and vulnerable children Protocols orphan drugs Regulations orphan drug Retinoic acid receptor-related orphan Retinoid-related orphan receptor Role of the Orphan Drug Act Serotonin receptors orphan Seven Orphan Cases Variations in Orphans School Enrollment, Selected Countries and Years